Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 22

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Inflammation mechanism and research progress of COPD
2024 Standout
2 intermediate papers

Works of Eduard Molins being referenced

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
2015
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
2014

Author Peers

Author Last Decade Papers Cites
Eduard Molins 455 269 104 111 20 582
Jing Cheng 174 45 168 51 25 611
Chuan‐Guo Guo 198 27 197 28 33 645
Andreas Bietenbeck 69 251 37 46 39 659
Tian Gu 215 91 80 36 29 558
Brandon S. Walker 129 180 65 16 39 568
Abdullah Çetin Tanrıkulu 340 32 124 47 38 699
Won-Chul Lee 133 134 181 20 28 706
E. Osborne Coates 236 49 170 27 24 591
Xiaoming Xu 31 62 72 39 27 596
Jeffrey K. Jopling 180 99 32 40 28 728

All Works

Loading papers...

Rankless by CCL
2026